It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Biomaterial wound dressings, such as hydrogels, interact with host cells to regulate tissue repair. This study investigates how crosslinking of gelatin-based hydrogels influences immune and stromal cell behavior and wound healing in female mice. We observe that softer, lightly crosslinked hydrogels promote greater cellular infiltration and result in smaller scars compared to stiffer, heavily crosslinked hydrogels. Using single-cell RNA sequencing, we further show that heavily crosslinked hydrogels increase inflammation and lead to the formation of a distinct macrophage subpopulation exhibiting signs of oxidative activity and cell fusion. Conversely, lightly crosslinked hydrogels are more readily taken up by macrophages and integrated within the tissue. The physical properties differentially affect macrophage and fibroblast interactions, with heavily crosslinked hydrogels promoting pro-fibrotic fibroblast activity that drives macrophage fusion through RANKL signaling. These findings suggest that tuning the physical properties of hydrogels can guide cellular responses and improve healing, offering insights for designing better biomaterials for wound treatment.
Impaired wound healing that leads to scar remains a clinical challenge. Here, the authors study the effects of hydrogel crosslinking on cellular behavior in skin wounds and its effect on immune and stromal cell activity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 University of California Irvine, Department of Biomedical Engineering, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California, Irvine, Department of Developmental and Cell Biology, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
2 University of California Irvine, Department of Biomedical Engineering, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
3 University of Illinois at Urbana-Champaign, Carle Illinois College of Medicine, Urbana-Champaign, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991)
4 University of California, Irvine, Department of Developmental and Cell Biology, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
5 University of California, Irvine, NSF-Simons Center for Multiscale Cell Fate Research, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California, Irvine, Department of Mathematics, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
6 University of California Irvine, Department of Biomedical Engineering, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California, Laboratory of Fluorescence Dynamics, The Henry Samueli School of Engineering, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
7 University of California, Irvine, NSF-Simons Center for Multiscale Cell Fate Research, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California, Irvine, Department of Mathematics, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California Irvine, Center for Complex Biological Systems, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
8 University of California, Los Angeles, Division of Dermatology, Department of Medicine, David Geffen School of Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Los Angeles, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Veterans Administration Greater Los Angeles Healthcare System, Department of Dermatology, Los Angeles, USA (GRID:grid.417119.b) (ISNI:0000 0001 0384 5381)
9 University of California, Irvine, Department of Developmental and Cell Biology, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California, Irvine, NSF-Simons Center for Multiscale Cell Fate Research, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California, Irvine, Sue and Bill Gross Stem Cell Research Center, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
10 University of California Irvine, Department of Biomedical Engineering, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California Irvine, UCI Edwards Lifesciences Foundation Cardiovascular Innovation and Research Center, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California, Irvine, Institute for Immunology, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California, Irvine, Molecular Biology and Biochemistry, Irvine, USA (GRID:grid.468726.9) (ISNI:0000 0004 0486 2046); University of California Irvine, Department of Chemical and Biomolecular Engineering, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)